Chronic kidney disease: The effect of CKD therapies on serum potassium levels

Nature Reviews Nephrology

Volumn 6, Issue 11, 2010, Pages 633-634

  Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM;

ADVERSE OUTCOME; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; DRUG FATALITY; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPOKALEMIA; KIDNEY FAILURE; MORTALITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SHORT SURVEY;

HUMANS; HYPERKALEMIA; HYPOKALEMIA; POTASSIUM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 78049380074     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.127     Document Type: Short Survey

References (10)

1. th edn (McGraw-Hill, new York, 2001).
2. Allon, M., Dansby, L. & Shanklin, N. Glucose modulaiton of the disposal of an acute potassium load in patients with end-stage renal disease. Am. J. Med. 94, 475-482 (1993).
3. Bonilla, S., Goecke, I. A., Bozzo, S., Alvo, M., Michea, L. & Marusic, E. T. effects of chronic renal failure on na,K-ATPase alpha 1 and alpha 2 transcription in rat skeletal muscles. J. Clin. Invest. 88, 2137-2141 (1991).
4. Bunchman, T. E. & Sinaiko, A. R. Renovascular hypertension presenting with hypokalemic metabolic alkalosis. Pediatr. Nephrol. 4, 169-170 (1990).
5. Fliser, D. Loop diuretics and thiazides\the case for their combination in chronic renal failure. Nephrol. Dial. Transplant 11, 408-410 (1996).
6. Weir, M. R. & Rolfe, M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin. J. Am. Soc. Nephrol. 5, 531-548 (2010).
7. Clayton, J. A., Rodgers, S., Blakey, J., Avery, A. & Hall, I. P. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br. J. Clin. Pharmacol. 61, 87-95 (2006).
8. Korgaonkar, S. et al. serum potassium and outcomes in CKD: insights from the RRi-CKD Cohort study. Clin. J. Am. Soc. Nephrol. 5, 762-769 (2010).
9. Einhorn, L. M. et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch. Intern. Med. 169, 1156-1162 (2009).
10. Hoes, A. W. et al. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann. Intern. Med. 123, 481-487 (1995).